Clinical site workflow and processes can have an enormous impact on the quality of data generated in a clinical trial. All too often, however, important factors like study product inventory, regulatory compliance and GCP practices, and patient compliance are not considered until late in the trial design phase. Tracie Di Pasquale at Myoderm explains that if your goal is to minimise risks and maximise the value of your data, these factors need to be considered early in the trial design process and communicated clearly to the
research staff.
 
http://jforcs.com/jcs/wp-content/uploads/2013/08/1-Keeping-your-Sites-Happy-Easing-Supply-Chain-Burdens-at-Clinical-Pharmacies2.pdf